125 related articles for article (PubMed ID: 14651214)
1. Maintained salivary function after brachytherapy in patients with head and neck carcinomas--evaluation using quantitative salivary gland scintigraphy.
Murata Y; Zhang L; Ishida R; Aung W; Taura S; Hossain M; Yoshimura R; Hoshina M; Akaike H; Sugaya T; Shibuya H
Acta Oncol; 2002; 41(7-8):684-8. PubMed ID: 14651214
[TBL] [Abstract][Full Text] [Related]
2. Maintained Salivary Function after Brachytherapy in Patients with Head and Neck Carcinomas - Evaluation Using Quantitative Salivary Gland Scintigraphy.
Murata Y; Zhang L; Ishida R; Aung W; Taura SI; Hossain M; Yoshimura RI; Hoshina M; Akaike H; Sugaya T; Shibuya H
Acta Oncol; 2002; 41(7-8):684-688. PubMed ID: 28758864
[TBL] [Abstract][Full Text] [Related]
3. Scintigraphy in prediction of the salivary gland function after gland-sparing intensity modulated radiation therapy for head and neck cancer.
Tenhunen M; Collan J; Kouri M; Kangasmäki A; Heikkonen J; Kairemo K; Mäkitie A; Joensuu H; Saarilahti K
Radiother Oncol; 2008 May; 87(2):260-7. PubMed ID: 18329118
[TBL] [Abstract][Full Text] [Related]
4. Accuracy requirements for head and neck intensity-modulated radiation therapy based on observed dose response of the major salivary glands.
Kapanen M; Collan J; Saarilahti K; Heikkonen J; Kairemo K; Tenhunen M
Radiother Oncol; 2009 Oct; 93(1):109-14. PubMed ID: 19435641
[TBL] [Abstract][Full Text] [Related]
5. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
[TBL] [Abstract][Full Text] [Related]
6. Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands.
Valdés Olmos RA; Keus RB; Takes RP; van Tinteren H; Baris G; Hilgers FJ; Hoefnagel CA; Balm AJ
Cancer; 1994 Jun; 73(12):2886-93. PubMed ID: 8199984
[TBL] [Abstract][Full Text] [Related]
7. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours.
Liem IH; Olmos RA; Balm AJ; Keus RB; van Tinteren H; Takes RP; Muller SH; Bruce AM; Hoefnagel CA; Hilgers FJ
Eur J Nucl Med; 1996 Nov; 23(11):1485-90. PubMed ID: 8854847
[TBL] [Abstract][Full Text] [Related]
8. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
[TBL] [Abstract][Full Text] [Related]
9. Prospective investigation and literature review of tolerance dose on salivary glands using quantitative salivary gland scintigraphy in the intensity-modulated radiotherapy era.
Lee SW; Kang KW; Wu HG
Head Neck; 2016 Apr; 38 Suppl 1():E1746-55. PubMed ID: 26875880
[TBL] [Abstract][Full Text] [Related]
10. 11C-methionine PET, a novel method for measuring regional salivary gland function after radiotherapy of head and neck cancer.
Buus S; Grau C; Munk OL; Bender D; Jensen K; Keiding S
Radiother Oncol; 2004 Dec; 73(3):289-96. PubMed ID: 15588873
[TBL] [Abstract][Full Text] [Related]
11. Impact of submandibular gland excision on salivary gland function in head and neck cancer patients.
Jaguar GC; Lima EN; Kowalski LP; Pellizon AC; Carvalho AL; Alves FA
Oral Oncol; 2010 May; 46(5):349-54. PubMed ID: 20227906
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Botulinum Toxin to Preserve Gland Function after Radiotherapy in Patients with Head and Neck Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blinded Phase I Clinical Trial.
Teymoortash A; Pfestroff A; Wittig A; Franke N; Hoch S; Harnisch S; Schade-Brittinger C; Hoeffken H; Engenhart-Cabillic R; Brugger M; Strauch K
PLoS One; 2016; 11(3):e0151316. PubMed ID: 26991494
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland-sparing helical tomotherapy for head and neck cancer: Preserved salivary function on quantitative salivary gland scintigraphy after tomotherapy.
Kreps S; Berges O; Belin L; Zefkili S; Petras S; Giraud P
Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Sep; 133(4):257-62. PubMed ID: 27291482
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic imaging of the salivary glands in patients undergoing radiotherapy of head and neck neoplasms].
Cardello P; Trinci M; Messineo D; Tuccimei M; Massa R; Marini M; Trinci M
Radiol Med; 1998 Mar; 95(3):224-31. PubMed ID: 9638170
[TBL] [Abstract][Full Text] [Related]
16. [Functional scintigraphy of salivary glands of the head during telecobalt radiotherapy].
Cha IH; Ritzl F
Strahlentherapie; 1983 Nov; 159(11):690-4. PubMed ID: 6658857
[TBL] [Abstract][Full Text] [Related]
17. [Quantitative salivary gland scintigraphy in head and neck cancer patients following radiotherapy].
Jiménez-Heffernan A; Gómez-Millán J; Sánchez De Mora E; Delgado Moreno J; Delgado Gil MM; Salgado C; Contreras Puertas P; Bermúdez Morales MC; López J; Paz Expósito J
Rev Esp Med Nucl; 2010; 29(4):165-71. PubMed ID: 20462671
[TBL] [Abstract][Full Text] [Related]
18. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
20. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
